Male breast cancer: Opportunities for increased research funding and clinical trial access
Male breast cancer: Opportunities for increased research funding and clinical trial access
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy
Adjuvant bisphosphonate therapy in breast cancer
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Long term use of aromatase inhibitors and compliance
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Cancer cells and the immune system: a natural story?
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction
Immuno-Oncology: a concept or already a reality?
Why are Immuno-Oncology compounds different?
The role of molecular pathways in therapeutic response and outcomes in breast cancer